Europe Market Report for Bone Graft Substitutes 2017 - MedCore

  • ID: 4327990
  • Report
  • Region: Europe
  • 612 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Anika Therapeutics
  • Croma-Pharma
  • Ferring
  • Integra Biologics
  • LCA Pharma
  • Orotech
  • MORE
General Report Contents:
  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
Scope: 2013-2023

As of 2016, the largest and fastest growing segment in the market was for synthetic bone graft substitutes. The strong growth of the synthetic market was a result of the affordability of synthetic products, as well as the strict regulations of allograft and DBM product usage throughout Europe. Furthermore, synthetic products have a very low risk of infection, which is another driver of growth.

Both the smallest and fastest declining segment was the DBM market. The decline in the DBM market was a result of high price and lack of clinical evidence regarding the product’s benefits. DBM products are commonly banned in the Scandinavian regions. While the majority of the 15 countries show a decline in DBM, both in price and quantity, consumption of DBM products in the U.K. and Switzerland are set to show moderate increases. This is due to the strong nation-wide beliefs in the products. Surgeons in these countries believe in the product and it is predicted that their demand will remain constant over the forecast period.

The second largest segment in 2016 was the allograft market. The larger ASP of allograft material allowed it to remain the market leader until recently. Allografts were particularly popular in the U.K. and Spain. While allograft material had been on the decline in Italy due to cultural disapproval, it is predicted that the Italian market will, over the forecast period, grow more accepting of using these materials.

Bones are biologically active tissues that allow for movement, provide protection for the body’s other organs and serve as a production center for red and white blood cells. When bones are diseased or damaged, bone grafts and bone graft substitutes are used for bridging the resulting void or for providing the support that has been lost. The transplanted (or implanted) material provides a scaffold on which the body can generate new bone tissue, thereby repairing the skeletal system. The most common usage of such materials is for dental implants to replace missing teeth. Within the orthopedic field, however, spinal fusion surgeries are the largest driver of bone graft and bone graft substitute usage. Direct competition for bone graft substitutes comes from bone morphogenetic proteins which, although more expensive, are more effective at stimulating bone growth. Another source of competition is the rise of the motion preservation market for spinal surgery.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Anika Therapeutics
  • Croma-Pharma
  • Ferring
  • Integra Biologics
  • LCA Pharma
  • Orotech
  • MORE
Executive Summary
European Orthopedic Biomaterials Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History


1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Osteology and Musculoskeletal System
2.2 Disease Pathology and Disorders
2.2.1 General Diagnostic
2.2.2 Osteoporosis
2.2.3 Osteoarthritis
2.2.4 Indication for Bone Graft Procedure
2.2.5 Indication for Cartilage Repair
2.2.6 Degenerative Disc Disease
2.3 Patient Demographics
2.3.1 General Statistics

3. Product Assessment
3.1 Product Portfolios
3.1.1 Bone Graft Substitutes
3.2 Regulatory Issues and Recalls
3.2.1 Bone Graft Substitutes
3.3 Clinical Trials
3.3.1 Bone Graft Substitutes

4. Country Profiles
4.1 Introduction
4.1.1 Population
4.1.2 GDP Per Capita
4.1.3 Price Index
4.2 Germany
4.3 France
4.4 United Kingdom
4.5 Italy
4.6 Spain
4.7 Benelux
4.8 Scandinavia
4.9 Austria
4.10 Switzerland
4.11 Portugal

5. Bone Graft Substitutes Market
5.1 Introduction
5.2 Market Overview
5.2.1 Bone Graft Substitute Market by Material
5.2.2 Bone Graft Substitute Market by Indication
5.3 Market Analysis and Forecast
5.3.1 Total Bone Graft Substitute Market
5.3.2 Total Allograft Bone Graft Substitute Market
5.3.2.1 Total Allograft Spine Market
5.3.2.1.1 Allograft Cervical Spine Market
5.3.2.1.2 Allograft Thoracolumbar Spine Market
5.3.2.2 Allograft Trauma and Reconstruction Market
5.3.2.3 Allograft Craniomaxillofacial Market
5.3.3 Total Synthetic Bone Graft Substitute Market
5.3.3.1 Total Synthetic Spine Market
5.3.3.1.1 Synthetic Cervical Spine Market
5.3.3.1.2 Synthetic Thoracolumbar Spine Market
5.3.3.2 Synthetic Trauma and Reconstruction Market
5.3.3.3 Synthetic Craniomaxillofacial Market
5.3.4 Total Demineralized Bone Graft Substitute Bone Matrix Market
5.3.4.1 Total Demineralized Bone Matrix Spine Market
5.3.4.1.1 Demineralized Bone Matrix Cervical Spine Market
5.3.4.1.2 Demineralized Bone Matrix Thoracolumbar Spine Market
5.3.4.2 Demineralized Bone Matrix Trauma and Reconstruction Market
5.3.4.3 Demineralized Bone Matrix Craniomaxillofacial Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis

Abbreviations

Appendix: Company Press Releases

List of Charts:
Chart 1 1: Orthopedic Biomaterials Market by Segment, Europe, 2013 - 2023
Chart 1 2: Orthopedic Biomaterials Market Overview, Europe, 2016 & 2023
Chart 4 1: Country Profile, Germany, 2016
Chart 4 2: Country Profile, France, 2016
Chart 4 3: Country Profile, United Kingdom, 2016
Chart 4 4: Country Profile, Italy, 2016
Chart 4 5: Country Profile, Spain, 2016
Chart 4 6: Country Profile, Benelux, 2016
Chart 4 7: Country Profile, Scandinavia, 2016
Chart 4 8: Country Profile, Austria, 2016
Chart 4 9: Country Profile, Switzerland, 2016
Chart 4 10: Country Profile, Portugal, 2016
Chart 5 1: Bone Graft Substitute Market by Segment, Europe, 2013 - 2023
Chart 5 2: Bone Graft Substitute Market Breakdown by Segment, Europe, 2016
Chart 5 3: Bone Graft Substitute Market Breakdown by Segment, Europe, 2023
Chart 5 4: Bone Graft Substitute Market by Indication, Europe, 2013 - 2023
Chart 5 5: Bone Graft Substitute Market Breakdown by Indication, Europe, 2016
Chart 5 6: Bone Graft Substitute Market Breakdown by Indication, Europe, 2023
Chart 5 7: Total Bone Graft Substitute Market, Europe, 2013 - 2023
Chart 5 8: Total Allograft Market, Europe, 2013 - 2023
Chart 5 9: Total Allograft Spine Market, Europe, 2013 - 2023
Chart 5 10: Allograft Cervical Spine Market, Europe, 2013 - 2023
Chart 5 11: Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023
Chart 5 12: Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023
Chart 5 13: Allograft Craniomaxillofacial Market, Europe, 2013 - 2023
Chart 5 14: Total Synthetic Market, Europe, 2013 - 2023
Chart 5 15: Total Synthetic Spine Market, Europe, 2013 - 2023
Chart 5 16: Synthetic Cervical Spine Market, Europe, 2013 - 2023
Chart 5 17: Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023
Chart 5 18: Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023
Chart 5 19: Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023
Chart 5 20: Total Demineralized Bone Matrix Market, Europe, 2013 - 2023
Chart 5 21: Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023
Chart 5 22: Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023
Chart 5 23: Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023
Chart 5 24: Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023
Chart 5 25: Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023
Chart 5 26: Leading Competitors, Bone Graft Substitute Market, Europe, 2016

List of Figures:
Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, Europe, 2016
Figure 1 2: Companies Researched in this Report, Europe, 2016
Figure 1 3: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe
Figure 1 4: Recent Events in the Orthopedic Biomaterials Market, Europe, 2015 - 2016
Figure 1 5: Orthopedic Biomaterials Markets Covered, Europe, 2016 (1 of 2)
Figure 1 6: Orthopedic Biomaterials Markets Covered, Europe, 2016 (2 of 2)
Figure 1 7: Key Report Updates
Figure 1 8: Version History
Figure 3 1: Bone Graft Substitutes Products by Company (1 of 3)
Figure 3 2: Bone Graft Substitutes Products by Company (2 of 3)
Figure 3 3: Bone Graft Substitutes Products by Company (3 of 3)
Figure 3 4: Class 2 Device Recall Endobon Xenograft Granules
Figure 3 5: Class 2 Device Recall Accell Evo3C Demineralized Bone Matrix Putty
Figure 3 6: Class 2 Device Recall Allofuse Dbm Putty 5Cc
Figure 3 7: Class 2 Device Recall Microfuse Bone Void Filler
Figure 3 8: Class 2 Device Recall Grafton
Figure 3 9: Class 2 Device Recall Optimum Expanse
Figure 3 10: Class 2 Device Recall Integra Mozaik
Figure 3 11: an Acdf Multi-Center Study Using Vivigen Cellular Bone Matrix
Figure 3 12: Cerament Treatment of Fracture Defects (Certify)
Figure 3 13: Synthetic Bone Graft Substitute vs. Autologous Spongiosa in Revision Anterior Cruciate Ligament Reconstruction
Figure 3 14: Assessment of Nanoss Bioactive 3D in the Posterolateral Spine
Figure 3 15: Attrax® Putty vs. Autograft in Xlif®
Figure 3 16: Evaluation of Fusion Rate Using K2M Vesuvius® Demineralized Fibers With K2M Everest® Spinal System
Figure 3 17: Clinical Evaluation of Genex® Ds in Instrumented Posterolateral Fusion
Figure 3 18: Efficacy and Safety of Surgifill™ on Spinal Fusion
Figure 3 19: Evaluation of Dtrax Graft in Patients With Cervical Degenerative Disc Disease
Figure 3 20: Comparison of Nanoss Bioactive With Autograft and Bone Marrow Aspirate to Autograft in the Posterolateral Spine
Figure 3 21: Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (Acdf) Using Cervios Chronos™ and Bonion™
Figure 5 1: Bone Graft Substitute Market by Segment, Europe, 2013 - 2023 (€M)
Figure 5 2: Bone Graft Substitute Market by Segment, Europe, 2013 - 2023 (Us$M)
Figure 5 3: Bone Graft Substitute Market by Indication, Europe, 2013 - 2023 (€M)
Figure 5 4: Bone Graft Substitute Market by Indication, Europe, 2013 - 2023 (Us$M)
Figure 5 5: Total Bone Graft Substitute Market, Europe, 2013 - 2023
Figure 5 6: Units Sold by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023
Figure 5 7: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 (€)
Figure 5 8: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 (Us$)
Figure 5 9: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 (€M)
Figure 5 10: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2013 - 2023 (Us$M)
Figure 5 11: Total Allograft Market, Europe, 2013 - 2023
Figure 5 12: Units Sold by Country, Total Allograft Market, Europe, 2013 - 2023
Figure 5 13: Average Selling Price by Country, Total Allograft Market, Europe, 2013 - 2023 (€)
Figure 5 14: Average Selling Price by Country, Total Allograft Market, Europe, 2013 - 2023 (Us$)
Figure 5 15: Market Value by Country, Total Allograft Market, Europe, 2013 - 2023 (€M)
Figure 5 16: Market Value by Country, Total Allograft Market, Europe, 2013 - 2023 (Us$M)
Figure 5 17: Total Allograft Spine Market, Europe, 2013 - 2023
Figure 5 18: Units Sold by Country, Total Allograft Spine Market, Europe, 2013 - 2023
Figure 5 19: Average Selling Price by Country, Total Allograft Spine Market, Europe, 2013 - 2023 (€)
Figure 5 20: Average Selling Price by Country, Total Allograft Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 21: Market Value by Country, Total Allograft Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 22: Market Value by Country, Total Allograft Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 23: Allograft Cervical Spine Market, Europe, 2013 - 2023
Figure 5 24: Units Sold by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023
Figure 5 25: Average Selling Price by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 (€)
Figure 5 26: Average Selling Price by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 27: Market Value by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 28: Market Value by Country, Allograft Cervical Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 29: Allograft Thoracolumbar Spine Market, Europe., 2013 - 2023
Figure 5 30: Units Sold by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023
Figure 5 31: Average Selling Price by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 (€)
Figure 5 32: Average Selling Price by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 33: Market Value by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 34: Market Value by Country, Allograft Thoracolumbar Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 35: Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023
Figure 5 36: Units Sold by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023
Figure 5 37: Average Selling Price by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 (€)
Figure 5 38: Average Selling Price by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 (Us$)
Figure 5 39: Market Value by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 (€M)
Figure 5 40: Market Value by Country, Allograft Trauma and Reconstruction Market, Europe, 2013 - 2023 (Us$M)
Figure 5 41: Allograft Craniomaxillofacial Market, Europe, 2013 - 2023
Figure 5 42: Units Sold by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023
Figure 5 43: Average Selling Price by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 (€)
Figure 5 44: Average Selling Price by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 (Us$)
Figure 5 45: Market Value by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 (€M)
Figure 5 46: Market Value by Country, Allograft Craniomaxillofacial Market, Europe, 2013 - 2023 (Us$M)
Figure 5 47: Total Synthetic Market, Europe, 2013 - 2023
Figure 5 48: Units Sold by Country, Total Synthetic Market, Europe, 2013 - 2023
Figure 5 49: Average Selling Price by Country, Total Synthetic Market, Europe, 2013 - 2023 (€)
Figure 5 50: Average Selling Price by Country, Total Synthetic Market, Europe, 2013 - 2023 (Us$)
Figure 5 51: Market Value by Country, Total Synthetic Market, Europe, 2013 - 2023 (€M)
Figure 5 52: Market Value by Country, Total Synthetic Market, Europe, 2013 - 2023 (Us$M)
Figure 5 53: Total Synthetic Spine Market, Europe, 2013 - 2023
Figure 5 54: Units Sold by Country, Total Synthetic Spine Market, Europe, 2013 - 2023
Figure 5 55: Average Selling Price by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 (€)
Figure 5 56: Average Selling Price by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 57: Market Value by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 58: Market Value by Country, Total Synthetic Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 59: Synthetic Cervical Spine Market, Europe, 2013 - 2023
Figure 5 60: Units Sold by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023
Figure 5 61: Average Selling Price by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 (€)
Figure 5 62: Average Selling Price by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 63: Market Value by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 64: Market Value by Country, Synthetic Cervical Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 65: Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023
Figure 5 66: Units Sold by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023
Figure 5 67: Average Selling Price by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 (€)
Figure 5 68: Average Selling Price by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 69: Market Value by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 70: Market Value by Country, Synthetic Thoracolumbar Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 71: Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023
Figure 5 72: Units Sold by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023
Figure 5 73: Average Selling Price by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 (€)
Figure 5 74: Average Selling Price by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 (Us$)
Figure 5 75: Market Value by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 (€M)
Figure 5 76: Market Value by Country, Synthetic Trauma and Reconstruction Market, Europe, 2013 - 2023 (Us$M)
Figure 5 77: Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023
Figure 5 78: Units Sold by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023
Figure 5 79: Average Selling Price by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 (€)
Figure 5 80: Average Selling Price by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 (Us$)
Figure 5 81: Market Value by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 (€M)
Figure 5 82: Market Value by Country, Synthetic Craniomaxillofacial Market, Europe, 2013 - 2023 (Us$M)
Figure 5 83: Total Demineralized Bone Matrix Market, Europe, 2013 - 2023
Figure 5 84: Units Sold by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023
Figure 5 85: Average Selling Price by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 (€)
Figure 5 86: Average Selling Price by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 (Us$)
Figure 5 87: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 (€M)
Figure 5 88: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2013 - 2023 (Us$M)
Figure 5 89: Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023
Figure 5 90: Units Sold by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023
Figure 5 91: Average Selling Price by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 (€)
Figure 5 92: Average Selling Price by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 93: Market Value by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 94: Market Value by Country, Total Demineralized Bone Matrix Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 95: Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023
Figure 5 96: Units Sold by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023
Figure 5 97: Average Selling Price by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 (€)
Figure 5 98: Average Selling Price by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 99: Market Value by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 100: Market Value by Country, Demineralized Bone Matrix Cervical Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 101: Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023
Figure 5 102: Units Sold by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023
Figure 5 103: Average Selling Price by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 (€)
Figure 5 104: Average Selling Price by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 (Us$)
Figure 5 105: Market Value by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 (€M)
Figure 5 106: Market Value by Country, Demineralized Bone Matrix Thoracolumbar Spine Market, Europe, 2013 - 2023 (Us$M)
Figure 5 107: Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023
Figure 5 108: Units Sold by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023
Figure 5 109: Average Selling Price by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 (€)
Figure 5 110: Average Selling Price by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 (Us$)
Figure 5 111: Market Value by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 (€M)
Figure 5 112: Market Value by Country, Demineralized Bone Matrix Trauma and Reconstruction Market, Europe, 2013 - 2023 (Us$M)
Figure 5 113: Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023
Figure 5 114: Units Sold by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023
Figure 5 115: Average Selling Price by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 (€)
Figure 5 116: Average Selling Price by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 (Us$)
Figure 5 117: Market Value by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 (€M)
Figure 5 118: Market Value by Country, Demineralized Bone Matrix Craniomaxillofacial Market, Europe, 2013 - 2023 (Us$M)
Figure 5 119: Drivers and Limiters, Bone Graft Substitute Market, Europe, 2016
Figure 5 120: Leading Competitors, Bone Graft Substitute Market, Europe, 2016
Figure 7 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Fidia
  • Medtronic
  • TRB Chemedica
  • Meda Pharma
  • Sanofi Genzyme
  • Depuy Synthes
  • Bioventus
  • Laboratoire Genevrier
  • Recordati
  • Stryker
  • RTI Biologics
  • Croma-Pharma
  • Zimmer Biomet
  • Anika Therapeutics
  • Bioiberica
  • Documedica
  • Ferring
  • Geistlich
  • Integra Biologics
  • Kuros
  • LCA Pharma
  • Orotech
  • Plasmaconcept AG
  • Stella PharmaceuticalsAlphatec Spine
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll